Cutera

Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cutera reports strong 2022 performance with focus on AviClear growth

Cutera's performance in 2022 showcased resilience and growth potential, driven by the successful AviClear launch. While facing revenue challenges in Q4 2022, the company is optimistic about achieving cash flow breakeven by Q4 2023. With a bullish outlook for 2023, Cutera aims to leverage its core business strength and accelerate AviClear sales.

Cutera reports Q1 revenue dip, focuses on AviClear growth

Cutera faces challenges in North American sales but sees growth opportunities internationally and with AviClear devices.
Financials show a loss in adjusted EBITDA and decreased cash, but the company is focused on improving execution and driving utilization rates.
Retention incentives have been effective, and steps are being taken to enhance performance and return to sustainable growth.

Cutera reports Q2 revenue decline, focuses on AviClear performance

Cutera reported Q2 2023 revenue of $61.2 million, down 5% YoY, with an adjusted EBITDA loss of $11.6 million. The company is focusing on AviClear performance, quality control, and core business growth.
Challenges include declining core capital business, operational issues, and macroeconomic challenges. Opportunities lie in optimizing AviClear utilization, enhancing reliability, and introducing new products for growth.
Cutera's commitment to addressing challenges, enhancing service levels, and executing a strategic plan for sustainable growth is evident. The organization is resilient in the face of macroeconomic pressures and is adapting its strategies for success.
Retention bonuses, successful employee retention, and efforts to improve quality control measures demonstrate Cutera's internal strengths. The company's strategic approach to product lines and growth showcases a positive outlook for the future.

Cutera reports Q3 revenue decline, focuses on cost reduction

Cutera faces revenue decline and operational challenges in Q3 2023, impacting full-year guidance. Plans for cost reduction, growth strategies, and personnel restructuring in progress. Positive outlook for achieving financial goals with confidence.

Cutera reports Q4 revenue growth, focuses on AviClear expansion

Cutera's Q4 performance reflects resilience with better-than-anticipated revenue and stable AviClear revenue.
Focus on operational excellence, global franchise building, and customer support positions Cutera for long-term success.
Efforts to address challenges like inventory management and customer adoption of new business models are crucial for growth.

Cutera reports mixed Q1 results, focuses on AviClear growth

Cutera's Q1 performance showed a revenue decline but growth in AviClear revenue, with a focus on operational excellence and building a strong AviClear franchise. The company faces challenges with declining customer site volumes and an uncertain timeline for patient demand. However, opportunities exist in international expansion, R&D innovation, and addressing future market needs.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first quarter ended March 31, 2023. First Quarter 2023 Financial and Operational Highlights Consolidated revenue of $55.0 million, a decrease of 5% as reported and a decrease of 1% in constant currency from the prior-year period. During Q1 2023, the Company generated $4.4 million in AviClear revenue, consi.

Cutera Announces First Quarter 2023 Financial Results

Cutera has sold off on major boardroom drama. CUTR has successfully launched AviClear, the biggest advance in acne treatment in decades.

Easy Channel Check Shows Cutera Has A Hit Product

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter of 2023 after the market close on Tuesday, May 9, 2023. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. To join the conference call, dial 1-800-319-4610 (domestic) or +1-631-89.

Cutera, Inc. to Announce First Quarter Results on May 9, 2023

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Cutera, Inc. (NASDAQ: CUTR) (“Cutera”). On April 12, 2023, Cutera announced the termination of its Executive Chairman and CEO for cause, on the recommendation of a special committee and the majority of its board of directors.

Securities Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Cutera, Inc. (NASDAQ: CUTR) Investors

SAN FRANCISCO--(BUSINESS WIRE)--Today J. Daniel Plants, Founder and Chief Investment Officer of Voce Capital Management LLC and a member of the Board of Directors (the “Board”) of Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), and David Mowry, also a Cutera Director – who together own approximately 7.

Cutera Directors J. Daniel Plants and David Mowry Respond to Special Committee's Attempt to Rewrite History

BRISBANE, Calif.--(BUSINESS WIRE)--The Special Committee of the Board of Directors (the “Special Committee”) of CUTERA, INC. (the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today issued an open letter to stockholders. The full text of the letter is as follows: Dear Fellow Stockholders, We are writing to you as five independent directors on the Cutera, Inc.

Cutera, Inc.'s Special Committee Updates Stockholders on Its Recent Steps to Protect Stockholder Interests

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, is honored to announce that this year marks the monumental 25th anniversary for the company as an industry leader and innovator.

Cutera® Celebrates 25 Years of Excellence in Innovation

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cutera, Inc. (“Cutera” or the “Company”) (NASDAQ: CUTR) on behalf of Cutera stockholders. Our investigation concerns whether Cutera has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On March 24, 2023, Cutera issued a press release "announc[ing] . . .

CUTERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cutera, Inc. on Behalf of Cutera Stockholders and Encourages Investors to Contact the Firm

Cutera Inc. CUTR, a maker of devices used for skincare and body-sculpting, on Thursday said it would hold a special shareholder meeting on June 9 to weigh whether to remove five directors — the latest in the drama over the company's CEO succession plans. The proposals on those removals, following concerns the directors were acting too slowly on those plans, were offered by two higher-ups that the company fired on Wednesday — executive chair Daniel Plants and chief executive David Mowry.

Cutera to hold meeting on board member removals, amid CEO succession drama

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced it will hold a Special Meeting of Stockholders (“Special Meeting”) on June 9, 2023, at 9:00 am PT in or near Brisbane, California for the purpose of considering proposals offered by J.

Cutera, Inc. to Hold Special Meeting of Stockholders

LOS ANGELES--(BUSINESS WIRE)---- $CUTR #CUTR--The Schall Law Firm Announces it is Investigating Claims Against Cutera, Inc.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cutera, Inc. and Encourages Investors with Losses to Contact the Firm

OAKLAND, Calif.--(BUSINESS WIRE)---- $CUTR #CUTR--Gibbs Law Group is investigating potential legal claims on behalf of Cutera investors.

Lost Money in Cutera, Inc.?

NEW YORK, April 12, 2023 /PRNewswire/ -- RTW Investments, LP ("RTW"), which manages funds holding approximately 9.3% of the outstanding shares of Cutera, Inc. (the "Company") (Nasdaq: CUTR), today announced that it was in favor of the Company holding the previously-called Special Meeting of Stockholders (the "Special Meeting") for the purpose of reconstituting the Board of Directors (the "Board") of the Company. RTW is concerned about the events that have transpired at the Company this past week, particularly with respect to the Board's removal of David Mowry as the Chief Executive Officer ("CEO") of the Company on April 11, 2023.

RTW Investments, LP Issues Statement Regarding Cutera's Special Meeting of Stockholders

Cutera Directors J. Daniel Plants and David Mowry Take Legal Action to Ensure Shareholders Have a Say in Composition of Cutera's Board and Selection of its Next CEO

Cutera Inc. CUTR, a Californian provider of dermatology equipment, said Wednesday it's terminating its executive chairman Daniel Plants and chief executive David Mowry for cause, on the recommendation of a special committee and the majority of its board. The move comes just days after Plants and Mowry issued a statement seeking the removal of five members of the board over concerns that they haven't made progress on a CEO succession plan.

Cutera terminates CEO David Mowry and Executive Chair Daniel Plants for cause in dispute over CEO succession plan

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced significant changes to the Company's executive leadership to focus on improving performance and results. The Board of Directors (the “Board”) has appointed Sheila A. Hopkins as Interim Chief Executive Officer (“CEO”) and Janet D. Widmann as Independent Chair of the Board, effective immediately.

Cutera, Inc. Announces Executive Leadership and Governance Changes

SAN FRANCISCO--(BUSINESS WIRE)--Today J. Daniel Plants, Founder and Chief Investment Officer of Voce Capital Management LLC and Executive Chairman of the Board of Directors (the “Board”) of Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), and David Mowry, Cutera's Chief Executive Officer and a Director – who together own approximately 7.0% of the outstanding shares of Cutera – shared a letter of support from Cutera senior employees that has been sent to the Company's Board.

David Mowry and J. Daniel Plants Share Letter of Support from Cutera Senior Leaders Sent to Company's Board

NEW YORK--(BUSINESS WIRE)--Pura Vida Investments, LLC (“Pura Vida”), a Delaware limited liability company with beneficial ownership of approximately 7% of the common stock of Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), today issued the following statement following the public turmoil amongst Cutera's Board of Directors (the “Board”).

Pura Vida Investments Calls for Cutera Board to Immediately Extend Director Nomination Deadline

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that based on the Company's April 7, 2023 filing of its Form 10-K for the period ended December 31, 2022 (“Form 10-K”), Nasdaq has determined that the Company is now in compliance with the periodic filing r

Cutera Regains Compliance with Nasdaq Listing Rules

SAN FRANCISCO--(BUSINESS WIRE)--Today J. Daniel Plants, Founder and Chief Investment Officer of Voce Capital Management LLC and Executive Chairman of the Board of Directors (the “Board”) of Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), and David Mowry, Cutera's Chief Executive Officer and a Director – who together own approximately 7.

J. Daniel Plants and David Mowry Call for Special Stockholder Meeting to Reconstitute Cutera's Board

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today acknowledged receipt of, and issued the following response to, a demand by J. Daniel Plants to call a special meeting of stockholders. In a letter dated April 3, 2023, Mr.

Cutera, Inc. Acknowledges Receipt of Special Meeting Demand from Daniel Plants

Altus Power

Callon Petroleum

CUTR, AMPS and CPE have been added to the Zacks Rank #5 (Strong Sell) List on April 6, 2023.

New Strong Sell Stocks for April 6th

Warby Parker

Clear Secure

Allogene Therapeutics Inc

Aravive Inc

Offerpad Solutions

Wayfair

While an extremely risky proposition, short-squeeze stocks – as meme traders demonstrated – can occasionally yield radical profitability. However, you don't want to just pick any beaten-down security as a possible comeback candidate.

7 Short-Squeeze Stocks That Could Explode in April

Big Lots

Cinemark Holdings

Ebix

GEO Group

GameStop

Medical Properties Trust

PetMed Express

Children's Place

Block

Trupanion

Voya Financial

Short sellers are getting bold again. And they've picked their favorite stock market targets to crash.

Short Sellers Are Betting Serious Money 11 Stocks Will Crash Soon

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc.

News for Cutera Stock (CUTR)